Access programs for investigational medicines
Information on Bristol Myers Squibb programs that support early and post study access to investigational medicines for eligible patients and healthcare providers.
Pre-approval access to investigational medicines
At Bristol Myers Squibb, we are doing everything we can to ensure that patients with serious or life-threatening diseases receive the benefit of our innovative medicines as quickly as possible.
Post study drug access to ww5 investigational medicinal products and approved products
Learn about Bristol Myers Squibb post study drug access programs that may provide eligible clinical trial participants continued access to study treatment after a trial ends.